| Dr Douglas Dawson, MD | |
|
214 14th Ave Sw, Sidney, MT 59270-3521 | |
| (406) 488-2380 | |
| Not Available |
| Full Name | Dr Douglas Dawson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 41 Years |
| Location | 214 14th Ave Sw, Sidney, Montana |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275519043 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 24291 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sidney Health Center | Sidney, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sidney Health Center | 0749181535 | 63 |
News Archive
Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.
Just as primary care provider shortages are becoming acute, retail-based clinics in pharmacies and grocery stores are set to fill the gap in accessible patient care. Yet in some states, access to this convenient care is constrained due to restrictive scope-of-practice laws.
Smartphone apps can track where we eat our meals, when we commute to and from work and how many minutes we exercise each day. Ten thousand steps today? Check.
Using the same strategy that a common virus employs to evade the human immune system, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine have modified adult stem cells to increase their survival - with the goal of giving the cells time to exert their natural healing abilities.
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.
› Verified 8 days ago
| Entity Name | Sidney Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376617191 PECOS PAC ID: 0749181535 Enrollment ID: O20040115000513 |
News Archive
Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.
Just as primary care provider shortages are becoming acute, retail-based clinics in pharmacies and grocery stores are set to fill the gap in accessible patient care. Yet in some states, access to this convenient care is constrained due to restrictive scope-of-practice laws.
Smartphone apps can track where we eat our meals, when we commute to and from work and how many minutes we exercise each day. Ten thousand steps today? Check.
Using the same strategy that a common virus employs to evade the human immune system, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine have modified adult stem cells to increase their survival - with the goal of giving the cells time to exert their natural healing abilities.
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Dawson, MD 214 14th Ave Sw, Sidney, MT 59270-3521 Ph: (406) 488-2102 | Dr Douglas Dawson, MD 214 14th Ave Sw, Sidney, MT 59270-3521 Ph: (406) 488-2380 |
News Archive
Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.
Just as primary care provider shortages are becoming acute, retail-based clinics in pharmacies and grocery stores are set to fill the gap in accessible patient care. Yet in some states, access to this convenient care is constrained due to restrictive scope-of-practice laws.
Smartphone apps can track where we eat our meals, when we commute to and from work and how many minutes we exercise each day. Ten thousand steps today? Check.
Using the same strategy that a common virus employs to evade the human immune system, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine have modified adult stem cells to increase their survival - with the goal of giving the cells time to exert their natural healing abilities.
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.
› Verified 8 days ago
Brett Russell Bennion, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 214 14th Ave Sw, Suite 101, Sidney, MT 59270 Phone: 406-488-2380 Fax: 406-488-2382 | |
Dr. Watson Mark Gutowski, M.D., F.A.A.P., FACS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 214 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2100 Fax: 406-488-2261 |